Where does Mozarc Medical US LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mozarc Medical US LLC ranks #7,740 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mozarc Medical US LLC hold?

Mozarc Medical US LLC holds 42 US utility patents granted between 2023 and 2025, spanning 20 technology areas.

What is Mozarc Medical US LLC's Innovation Score?

Mozarc Medical US LLC has an Innovation Score of 59.5 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Mozarc Medical US LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Mozarc Medical US LLC.

What does claim depth mean for Mozarc Medical US LLC's patents?

Mozarc Medical US LLC's patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mozarc Medical US LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mozarc Medical US LLC

Q: What technology areas does Mozarc Medical US LLC focus on?

Mozarc Medical US LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 38 patents, ranking #194 of 3,490 assignees active in that subclass. Grants appear in 20 CPC subclasses total.

USPTO PatentsView assignee record - 42 granted patents across 20 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mozarc ranks #7,740 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 20 technology areas.

#7,740
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.5/100): 17.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7740 · US Corporation #7,740 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 42 grants
UPPER-Q #7,740/49,997
PHOTO-FINISH Merus
CPC-FOCUS A61M · 20 areas
INNOV-PAR 59.5/100
CLAIMS-RICH 17.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Merus N.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mozarc’s 59.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (22%) Velocity 20.0 pts (34%) Breadth 15.8 pts (27%) Claim depth 10.6 pts (18%)

Qualcomm Incorporated · highest

85
Docusign · near

59
Roche Sequencing… · near

59
HD Hyundai Infracore · near

59
Institute FOR… · near

59
Mozarc Medical US · this assignee

59
3D Lighting… · lowest

7

What this shows Mozarc's Innovation Score is 59.5/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mozarc?

Each dot is one of Mozarc’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mozarc’s own 17.7 claims/patent is ABOVE the 8.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mozarc vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mozarc's grants concentrate

Mozarc Medical US LLC is a focused PatentsView assignee: 20 CPC subclasses with 90.5% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (14 grants) versus a trough of 13 in 2024. By volume, Mozarc sits between Merus N.V. and Neutrik AG.

Mozarc's three-year grant acceleration

Mozarc Medical US LLC shows 27 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Merus

42
Microsoft Mobile…

42
Modne

42
Morinaga Milk Ind…

42
Nanthealth

42
Nippon Steel & Su…

42
Nantcell

42
Neutrik

42
Mozarc Medical US ◀

42

What this shows Mozarc holds 42 patents at rank #7,740, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mozarc

By rank, the assignees closest to #7,740 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Mozarc's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mozarc, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Mozarc ranks #194 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (59 here).

HD Hyundai Infracore Co., Ltd. 59 Institute FOR Information Industry 59 Docusign, Inc. 59 Roche Sequencing Solutions, Inc. 59

Mozarc's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Mozarc Medical US LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	14	33.3%
2024	13	31.0%
2025partial year	15	35.7%

Which technologies does Mozarc Medical US LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 38

A61B - DIAGNOSIS; SURGERY; Identification 8

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 7

B01D - Separation 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

D01D - Mechanical Methods OR Apparatus IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR Ribbons 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

G06F - Electric Digital Data Processing 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mozarc Medical US LLC's patent record in context - here's where to go next.

Mozarc Medical US LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 90.5% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #7,740 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mozarc Medical US LLC against Merus N.V., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.